Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$38,483,418
-$5,778,527 QoQ
Shares Held
667,883
-8.5% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
1.59%
of 13F equity value
Holder Rank
#195
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEIZERT CAPITAL PARTNERS, LLC holds $92,983,054 across 6 Drug Manufacturers - General names. BMY ranks #2 (41.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
162,741 | $41,331,331 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
667,883 | $38,483,418 | |
| 3 | AMGN |
Amgen Inc
|
18,902 | $6,844,792 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
37,822 | $4,778,431 | |
| 5 | ABBV |
AbbVie Inc.
|
3,980 | $1,001,527 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,230 | $543,555 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,483,418 | 667,883 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $44,261,945 | 729,793 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $40,892,830 | 758,117 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $32,444,579 | 719,392 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $32,994,956 | 712,788 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $42,913,844 | 703,621 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $39,859,811 | 704,735 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $37,110,721 | 717,254 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $25,225,529 | 607,405 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $34,866,256 | 642,933 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $25,726,834 | 501,400 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $30,209,936 | 520,502 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $32,744,958 | 512,040 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $30,061,964 | 433,732 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $28,727,764 | 399,274 | Shares | Sole | 2023-03-28 | |
| 2022-09-30 | $30,068,368 | 422,962 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $32,494,924 | 422,012 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $31,503,316 | 431,375 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $27,187,031 | 436,039 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,224,382 | 71,394 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,415,810 | 36,154 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,182,719 | 34,575 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,983,829 | 48,103 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,810,719 | 46,620 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $2,185,948 | 37,176 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $932,753 | 16,734 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||